Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BriaCell Therapeutics (BCTXW)

BriaCell Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCTXW
DateTimeSourceHeadlineSymbolCompany
17/12/202421:05GlobeNewswire Inc.BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting ProceduresNASDAQ:BCTXWBriaCell Therapeutics Corporation
17/12/202421:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCTXWBriaCell Therapeutics Corporation
17/12/202421:05GlobeNewswire Inc.BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting ProceduresNASDAQ:BCTXWBriaCell Therapeutics Corporation
16/12/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
16/12/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
13/12/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
13/12/202421:05GlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $5.5 Million Public OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
13/12/202412:50GlobeNewswire Inc.BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/12/202422:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/12/202411:06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
12/12/202404:54GlobeNewswire Inc.BriaCell Therapeutics Announces Pricing of $5.5 Million Public OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/12/202422:21Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
11/12/202421:05GlobeNewswire Inc.BriaCell Therapeutics Announces Proposed Public OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/12/202412:50GlobeNewswire Inc.BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®NASDAQ:BCTXWBriaCell Therapeutics Corporation
10/12/202411:06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
05/12/202412:45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
02/12/202412:50GlobeNewswire Inc.BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
26/11/202412:50GlobeNewswire Inc.BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
25/11/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
25/11/202412:50GlobeNewswire Inc.BriaCell Provides Update to its Board of DirectorsNASDAQ:BCTXWBriaCell Therapeutics Corporation
21/11/202412:50GlobeNewswire Inc.BriaCell Announces First Patient Dosed with Bria-OTSâ„¢ in Metastatic Breast Cancer StudyNASDAQ:BCTXWBriaCell Therapeutics Corporation
14/11/202417:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
08/11/202412:50GlobeNewswire Inc.BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC ConferenceNASDAQ:BCTXWBriaCell Therapeutics Corporation
04/11/202412:50GlobeNewswire Inc.BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13NASDAQ:BCTXWBriaCell Therapeutics Corporation
01/11/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
22/10/202411:50GlobeNewswire Inc.BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival DataNASDAQ:BCTXWBriaCell Therapeutics Corporation
15/10/202411:50GlobeNewswire Inc.BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal StudyNASDAQ:BCTXWBriaCell Therapeutics Corporation
02/10/202420:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
02/10/202420:05GlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $5 Million OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
02/10/202414:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:BCTXW